Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cory Adamson

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Expert Opinion on Investigational Drugs|October 12, 2020
Emerging and investigational targeted chemotherapy and immunotherapy agents for metastatic brain tumorsJ Tanner McMahon, Razan R Faraj, David Cory Adamson
World Neurosurgery|December 20, 2014
Radiation-induced malignant gliomas: a current reviewAladine A Elsamadicy, Ranjith Babu, John P Kirkpatrick, et al.
International Journal of Oncology|September 24, 2015
OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathwaysJing Li, Chunhui Di, Jenny Jing, et al.
International Journal of Oncology|May 9, 2014
Adherens junctional associated protein-1: a novel 1p36 tumor suppressor candidate in gliomas (Review)Liang Zeng, Brian E Fee, Miriam V Rivas, et al.
International Journal of Oncology|February 1, 2014
The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBMLiang Zeng, Chunsheng Kang, Chunhui Di, et al.
International Journal of Oncology|November 9, 2017
AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survivalChunhui Di, Nikol Mladkova, James Lin, et al.
Expert Opinion on Therapeutic Targets|May 5, 2009
Glioblastoma multiforme: a review of therapeutic targetsOkezie O Kanu, Ankit Mehta, Chunhui Di, et al.
Molecular Cancer Research : MCR|January 14, 2012
Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastomaNingjing Lin, Chunhui Di, Kathy Bortoff, et al.
CNS Neuroscience & Therapeutics|February 4, 2014
AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganizationLei Han, Kai-Liang Zhang, Jun-Xia Zhang, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Expert Opinion on Investigational Drugs|October 12, 2020
Emerging and investigational targeted chemotherapy and immunotherapy agents for metastatic brain tumorsJ Tanner McMahon, Razan R Faraj, David Cory Adamson
World Neurosurgery|December 20, 2014
Radiation-induced malignant gliomas: a current reviewAladine A Elsamadicy, Ranjith Babu, John P Kirkpatrick, et al.
International Journal of Oncology|September 24, 2015
OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathwaysJing Li, Chunhui Di, Jenny Jing, et al.
International Journal of Oncology|May 9, 2014
Adherens junctional associated protein-1: a novel 1p36 tumor suppressor candidate in gliomas (Review)Liang Zeng, Brian E Fee, Miriam V Rivas, et al.
International Journal of Oncology|February 1, 2014
The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBMLiang Zeng, Chunsheng Kang, Chunhui Di, et al.
International Journal of Oncology|November 9, 2017
AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survivalChunhui Di, Nikol Mladkova, James Lin, et al.
Expert Opinion on Therapeutic Targets|May 5, 2009
Glioblastoma multiforme: a review of therapeutic targetsOkezie O Kanu, Ankit Mehta, Chunhui Di, et al.
Molecular Cancer Research : MCR|January 14, 2012
Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastomaNingjing Lin, Chunhui Di, Kathy Bortoff, et al.
CNS Neuroscience & Therapeutics|February 4, 2014
AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganizationLei Han, Kai-Liang Zhang, Jun-Xia Zhang, et al.
Pageof 2